Four leading companies, AlexiGen, Sensoria Health, Defender, and Anderson Medical Supplies, have announced a strategic partnership aimed at addressing the critical issue of diabetic foot ulcers (DFUs) through the introduction of the 'Alternative to Amputation: Footwear as a Service (FAAS): A Remote Patient Monitoring Artificial Intelligence Platform'. This innovative platform integrates biologics, remote monitoring technology, advanced wound care, and mechanical offloading footwear to enhance DFU management.
Diabetic foot ulcers affect about 15% of individuals with diabetes and are the primary cause of lower extremity amputations in the U.S. The partnership leverages the unique strengths of each company: Anderson Medical Supplies provides clinical services, AlexiGen contributes skin graft products, while Defender and Sensoria Health offer the Smart Boot and remote monitoring services, respectively. The Smart Boot, enhanced with Sensoria's technology, is currently under evaluation in a NIH-funded study by the University of Southern California and Baylor College of Medicine.
Davide Vigano, CEO of Sensoria Health, highlighted the collaborative effort's significance in reducing amputations. The Sensoria RPM platform allows clinicians to monitor patient adherence to treatment plans in real-time, improving the effectiveness of AlexiGen's skin substitutes and patient outcomes. With studies showing that 14% to 24% of diabetic foot ulcer patients may face amputation, this partnership introduces a potentially transformative approach to DFU care.
The FAAS Platform represents a holistic solution, combining technology and clinical expertise to offer an alternative to amputation. As the platform rolls out, it holds the promise of revolutionizing DFU treatment, enhancing patient quality of life, and alleviating the economic impact of diabetes-related amputations. The initiative is now seeking early adopters among healthcare professionals and organizations to pioneer this integrated approach to diabetic foot ulcer management.
